Over the last two years, fentanyl drug poisoning has taken an immense toll on our membership, with too many fatal overdoses and long-term health impacts of recurring overdose within our community. We continue to fight for the options people need to have more control and choice over how they manager their drug use and health.
The Cannabis Substitution Project is one of these options – cannabis is a safe and effective alternative to opiate use for many people, and we promote diverse options for drug maintenance and improved health by providing cannabis substitution on a daily basis to program participants.
We see between 80-100 participants daily, and we work with participants on individualized management plans through weekly meetings to make sure participants are finding the doses and uses of various cannabis options that work best for them.
This project runs thanks to support from dispensaries, and the volunteer work of many individuals supportive of the project. We thank all of these contributors for their hard work in supporting this un-unfunded and much-needed pilot project but we need more help!
Interested in supporting this program? Make a donation below. [wpedon id=600]
SOLID is a naloxone distribution site: if you or someone you know is at risk of overdose, 20 minute drop-in trainings are Wednesdays 2:30pm. Email firstname.lastname@example.org to book a training for a larger group, or to let us know you’re dropping in.
Six months ago, the Province declared a public health emergency – we demand immediate, local emergency responses. Working on an application for a federal exemption for supervised consumption services is NOT an emergency response – an emergency response MUST be the IMMEDIATE creation of SCS services. [read the full demands and recommendations here]
Interim responses are required in Victoria NOW. These must include:
1. Access to widespread Opiate Substitution Therapy (OST) dispensing, including prescription heroin through HR sites and community health clinics.
2. Interim crisis funding for harm reduction agencies that are responding to overdose events and training others in Naloxone. (done)
3. Satellite harm reduction sites immediately established and staffed in locations experiencing overdose events. (done)
4. Interim exemption policy by provincial government to allow the creation of SCS while federal approval is pending. (done)
5. Access to drug testing equipment
6. Suspend local police enforcement of the war on people who use drugs.
7. Meaningful engagement of people who use(d) drugs in responses to ODs, and engagement of service users locally and at BC’s Joint Task Force and the Federal Opioid Summit
AGM Tuesday Dec 13, 1-3pm
Motions for bylaw changes include:
1/ changing the maximum number of directors: from ‘5’ to “9, a maximum of 2 of whom can be people who do not identify as current or former persons who use drugs. ”
2/ adding a bylaw provision for the removal of a director: “The members may by special resolution remove a Director before the expiration of their term of office, and may elect a successor to complete the
term of office, or, the Board of Directors may, by a 2/3rds majority vote of a quorum of Board members present, excluding the Director in question, remove a Director before the expiration of their term of office for any one of the following reasons:
a. Failing to advise of their absence for two (2) consecutive Board meetings,
b. Failing to attend three (3) consecutive Board meetings,
c. Failing to attend one third of the total number of Board meetings in a 12 month period, or
d. breaching the Directors Code of Conduct as published from time to time by the Board of Directors.
Notice of intent to vote for removal of a Director shall be issued to the Director in question at least 14 days prior to such vote to remove.”
2nd and 4th Mondays of the month. 1 -2 pm. Meet up for information sharing and support for women with HepC. Food, $5 stipends, bus tickets, and lots of updates and information about HepC as conditions and treatment continues to change. Open to all self-identified women with HepC.